When nations compete
Why ‘most favoured nation’ matters for medicine access in Australia
While governments worldwide are debating the impact of MFN on medicine access, we have analysed what it means for Australia.
In our report, you’ll discover:
- How MFN could reshape Australia’s position in global pricing.
- The risks to innovation, patient access, and system sustainability.
- Strategies for executives, payers, and policy leaders to consider.
This is the hottest policy topic in life sciences right now — and we’re the first to put it on the agenda in Australia.
Download the MFN report and discover other key insights from Evohealth.